003020.SZ
立方制药
SZSE · Healthcare · C 制造业 · CN
CNY 17.49
−3.64%Margins
Gross margin
65.2%
EBITDA margin
17.4%
EBIT margin
11.6%
Net margin
10.5%
FCF margin
8.2%
8.8%
Return on equity
6.1%
Return on assets
9.4%
Return on invested capital
0.59x
Asset turnover
CNY 240.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026